| Literature DB >> 30059145 |
Yingying Guo1, Xiaoyan Chu2, Neil J Parrott3, Kim L R Brouwer4, Vicky Hsu5, Swati Nagar6, Pär Matsson7, Pradeep Sharma8, Jan Snoeys9, Yuichi Sugiyama10, Daniel Tatosian2, Jashvant D Unadkat11, Shiew-Mei Huang5, Aleksandra Galetin12.
Abstract
This white paper examines recent progress, applications, and challenges in predicting unbound and total tissue and intra/subcellular drug concentrations using in vitro and preclinical models, imaging techniques, and physiologically based pharmacokinetic (PBPK) modeling. Published examples, regulatory submissions, and case studies illustrate the application of different types of data in drug development to support modeling and decision making for compounds with transporter-mediated disposition, and likely disconnects between tissue and systemic drug exposure. The goals of this article are to illustrate current best practices and outline practical strategies for selecting appropriate in vitro and in vivo experimental methods to estimate or predict tissue and plasma concentrations, and to use these data in the application of PBPK modeling for human pharmacokinetic (PK), efficacy, and safety assessment in drug development.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30059145 PMCID: PMC6197917 DOI: 10.1002/cpt.1183
Source DB: PubMed Journal: Clin Pharmacol Ther ISSN: 0009-9236 Impact factor: 6.875